home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Leveraging the Target Product Profile (TPP) to Maximize Breakthrough Potential

 
  February 18, 2022  
     
 


xtalks.com, webinar
Thursday, March 31, 2022 | 10am EDT (NA) / 3pm BST (UK) / 4pm CEST (EU-Central)


Who Should Attend?

  • R&D Leadership
  • Commercial Leadership
  • Commercial Affairs
  • Business Development
  • Regulatory Affairs
  • Market Access
  • Project Management

What You Will Learn

Webinar attendees will learn:

  • Best practices in the design and use of a target product profile
  • Required inputs and processes for developing an effective target product profile
  • The target product profile’s role in achieving a product’s breakthrough potential
 
 
Organized by: xtalks.com
Invited Speakers:
http://Robb%20Lawrence,%20Premier%20Consulting

Robb Lawrence, Senior Vice President Commercial Strategy, Premier Consulting

In 2020, Robb Lawrence joined Premier Consulting as Senior Vice President of Commercial Strategy with responsibility for Premier Consulting’s expanding suite of commercial strategy solutions.

Prior to joining Premier Consulting, Lawrence spent 10 years as a health care entrepreneur, building companies designed to bring new and innovative pharmaceutical products to the US market. He founded and served as CEO of two virtual specialty pharmaceutical companies, TLC Therapeutics and Tropical Disease Therapeutics (TDT), both of which were created to execute on co-development partnerships with larger global pharma companies. Prior to founding TLC and TDT, Lawrence launched and managed the day-to-day operations of Salient Consulting, a boutique strategy consulting practice focused on strategic product development and go-to-market strategies for novel medicines.

Prior to his entrepreneurial endeavors, Lawrence held numerous positions at Merck and Company and played a key role on the marketing team responsible for launching Merck’s Diabetes Franchise (Januvia® and Janumet®).

Lawrence earned a Master of Business Administration with a focus in Health Sector Management from Duke University’s Fuqua School of Business and a Bachelor of Arts in Literature and History from Wake Forest University.

 
Deadline for Abstracts: na
 
Registration: Leveraging the Target Product Profile (TPP) to Maximize Breakthrough Potential - Xtalks
E-mail: shunte@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.